Concord Biotech Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov '24 Nov 22, 2024	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020
Market Capitalization	211,252	159,100	-	-	-	-
Enterprise Value	208,448	157,079	-	-	-	-
Last Close Price	2019.30	1512.33	-	-	-	-
PE Ratio	64.41	51.64	-	-	-	-
Forward PE	48.91	43.46	-	-	-	-
PS Ratio	19.45	15.65	-	-	-	-
PB Ratio	13.29	10.42	-	-	-	-
P/TBV Ratio	13.38	10.42	-	-	-	-
P/FCF Ratio	108.96	88.50	-	-	-	-
P/OCF Ratio	71.01	59.93	-	-	-	-
PEG Ratio	1.74	1.42	-	-	-	-
EV/Sales Ratio	19.20	15.45	-	-	-	-
EV/EBITDA Ratio	44.72	35.81	-	-	-	-
EV/EBIT Ratio	50.54	40.61	-	-	-	-
EV/FCF Ratio	107.51	87.37	-	-	-	-
Debt / Equity Ratio	0.00	0.01	0.02	0.06	0.09	0.07
Debt / EBITDA Ratio	0.01	0.02	0.09	0.22	0.27	0.24
Debt / FCF Ratio	0.02	0.05	0.31	1.19	-	-
Asset Turnover	0.65	0.63	0.60	0.57	0.58	-
Inventory Turnover	1.17	1.16	0.94	0.99	0.88	-
Quick Ratio	4.43	4.55	2.43	2.71	3.92	3.45
Current Ratio	6.60	6.30	3.79	4.08	5.74	4.68
Return on Equity (ROE)	22.27%	21.88%	20.06%	16.64%	26.55%	-
Return on Assets (ROA)	15.58%	15.04%	13.26%	11.47%	17.80%	-
Return on Capital (ROIC)	17.39%	16.92%	15.07%	12.70%	19.78%	-
Earnings Yield	1.55%	1.94%	-	-	-	-
FCF Yield	0.92%	1.13%	-	-	-	-
Dividend Yield	0.43%	0.58%	-	-	-	-
Payout Ratio	27.91%	23.19%	22.31%	40.31%	2.43%	47.63%
Total Shareholder Return	0.48%	0.58%	-	-	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.